veterinary drug competition, gradually to the cost line, low gross profit and cold small varieties and other three levels of differentiation.

Since the epidemic was released, especially since 2023, the semi-annual reports of many veterinary drug companies have looked so "horrible". The reason is "puzzling"; the dream can develop rapidly, but the future is "confused"! What's wrong with veterinary drugs? Is the veterinary drug industry failing?

In fact, there is no bad industry, only bad enterprises! All the poor management of veterinary drug enterprises should not use the market to talk about things, or shirk them accordingly; they should not use national policies to talk about things, or blame natural disasters. Because these are all external situations, not the enterprise itself, let alone the fundamental elements of poor business operation! All the external reasons for

are nothing more than telling those better-run enterprises or competitors that it is your impact on the enterprises of the new external situation of veterinary drugs. You do not have a correct insight into the control and thinking level, and you have not implemented the response into the adjustment and implementation of the enterprise's competitive development strategy. In the final analysis: that is, poor management has led to the current "situation"!

So, let's look at the current domestic veterinary drugs, which are dependent on the development and existence of the food and animal breeding industry! The characteristics of domestic food and animal breeding industry determine the veterinary drug products serving commercial farms, and the characteristics of veterinary drugs will be determined by the "economic" characteristics of food and animal breeding.

Then, the veterinary drug industry has undergone adjustments in the past ten years since the fast-growing chicken incident, and the domestic food and animal breeding industry has far exceeded demand. This trend, whether you recognize it or not, is the current fact and the reality for a long time to come.

It can be said that the domestic livestock and poultry breeding industry before 2008 was short of supply or tight! Today's epoch-making changes, the impact on veterinary drugs can be described as "huge". That is, the current and future veterinary drug industry has entered the development stage of "universal medicine!

Here, we classify veterinary drugs: new drugs, special drugs and general drugs. The pharmacopoeia varieties commonly used in clinical practice and with large market demand are commonly referred to as general drugs. At present, the main market circulation is general drugs. In the past era, under the packaging of artificial differentiation design and marketing planning, the stage of doubling the price of general medicine and high profits has long passed.

With the continuous increase of national supervision, the illegal cost of illegal veterinary drug enterprises is increasing, veterinary drugs are bound to become more and more homogeneous, price encounters are inevitable, the era of universal drug parity will come sooner or later, and the vast majority of general drug enterprises will be eliminated.

Because veterinary drugs are all pharmacopoeia varieties, many enterprises can apply for production. Even if they are labeled as gimmicks such as technology and imported raw materials, the price is ridiculously high, but it will not increase exponentially. As a preparation enterprise, the price of the general medicine produced should not be so large.